Infarct size and vascular hemodynamics were measured 24 h after middle cerebral artery (MCA) occlu sion in mice genetically deficient in the endothelial nitric oxide synthase (eNOS) isoform , eNOS mutant mice de veloped larger infarcts (21 %) than the wild-type strain when assessed 24 h after intraluminal filament occlusion , Moreover, regional CBF values recorded in the MCA ter ritory by laser-Doppler flow me try were more severely reduced after occlusion and were disproportionately re duced during controlled hemorrhagic hypotension in au toregulation experiments , Unlike the situation in wild type mice, nitro-L-arginine superfusion (I mM) dilated pial arterioles of eNOS knockout mice in a closed cranial window preparation. As noted previously, eNOS mutant mice were hypertensive. However, infarct size remained Nitric oxide (NO) is synthesized from L-arginine by the action of one of the following NO synthase (NOS) isoforms: neuronal (Type I; nNOS), endo thelial (Type III; eNOS), and inducible (Type II; iNOS) NOS (Nathan and Xie, 1994; Snyder, 1995) . NOS is found in neurons [nNOS (Bredt and Snyder, 1990)]. endothelial cells [eNOS (Palmer et aI. , 1988)], astrocytes [iNOS (Murphy et aI. , 1993)]. and perivascular nerve fibers [nNOS (Nozaki et aI. , 1993)]. NO has been implicated in many normal and abnormal functions such as regulation of vascular tone (Moncada et al. , 1991; Knowles and Moncada, 
increased despite lowering blood pressure to normoten sive levels by hydralazine treatment. Systemic adminis tration of nitro-L-arginine decreased infarct size in eNOS mutant mice (24%) but not in the wild-type strain. This finding complements published data showing that nitro L-arginine increases infarct size in knockout mice ex pressing the eNOS but not the neuronal NOS isoform (i.e., neuronal NOS knockout mice). We conclude that NO production within endothelium may protect brain tis sue, perhaps by hemodynamic mechanisms, whereas neuronal NO overproduction may lead to neurotoxicity. Key Words: Brain infarction-Endothelial nitric oxide synthase-Middle cerebral artery occlusion-Regional cerebral blood flow. 1992), platelet aggregation (Radomski et aI., 1990) , N-methyl-D-aspartate-mediated cytotoxicity (Daw son et aI. , 1991) , and neurotransmission (Snyder and Bredt, 1991; Dawson et aI., 1992; O'Dell et aI., 1994) .
Recently, an important, albeit complex role for NO has been proposed in the pathophysiology of cerebral ischemia (Dalkara and Moskowitz, 1994; ladecola et aI. , 1994) . Whether NO is beneficial or detrimental to brain, however, remains controver sial. Since NO is a diffusible, short-lived, and reac tive free radical gas that is difficult to measure in vivo (Archer, 1993) , most studies examining isch emic outcomes have based their conclusions on re sults following NOS inhibition by arginine ana logues such as nitro-L-arginine or nitro-L-arginine methyl ester. These inhibitors, however, lack en zyme selectivity and block multiple isoforms (Rees et aI. , 1990) . This non selectivity might account in part for the discrepant outcomes after administra tion of NOS inhibitors following middle cerebral ar tery (MeA) occlusion.
Targeted gene disruption of the e-or nNOS iso forms provides a novel approach to dissect the rel evance of NO in brain ischemia. We previously re ported that mice deficient in nNOS gene expression were relatively resistant to brain injury after perma nent focal cerebral ischemia (Huang et aI. , 1994) . In this report, we document the consequences of MCA occlusion in mice lacking eNOS gene expression.
MATERIALS AND METHODS
Wild-type (SV-129 and C57 Black/6; Taconic Farms, Germantown, NY, U.S.A.) and eNOS mutant (Huang et a!., 1995) male and female mice weighing 2�26 g were housed under diurnal lighting conditions and allowed free access to food and water ad libitum. Nitro-L-arginine, nitro-D-arginine, hydralazine hydrochloride, and 2,3,5triphenyltetrazolium chloride (TTC) were purchased from Sigma.
Focal ischemia study
Mice were anesthetized with 2% halothane for induc tion and maintained on 1 % halothane in 70/30% nitrous oxide/ oxygen by mask. The right femoral artery was can nulated with PE-IO polyethylene tubing for arterial blood pressure measurement (Gould, Valley View, OH, U.S.A.) and blood gas determination (Corning 178; Ciba Corning Diag., Medford, MA, U.S.A.). Rectal tempera ture was maintained between 36.5 and 37.soC with a ho meothermic blanket system (YSI, Yellow Springs, OH, U.S.A.).
Focal cerebral ischemia was induced by occlusion of MCA using the intraluminal filament technique (Zea Longa et a!., 1989; Huang et a!., 1994) . Through a ventral midline incision, the right common and external carotid arteries were isolated and ligated. A microvascular clip (Zen temporary clip; Ohwa Tsusho, Tokyo, Japan) was temporarily placed on the internal carotid artery and the pterygopalatine artery. An 8-0 nylon monofilament (Ethi con, Somerville, NJ, U.S.A.) coated with silicone was introduced through a small incision in the common ca rotid artery and advanced 10 mm distal to the carotid bifurcation so as to occlude the MCA and posterior com municating artery. The wound was sutured and the ani mal returned to its cage and allowed free access to water and food. Twenty-four hours later, animals were killed with an overdose of pentobarbital and the brains were removed and sectioned coronally into five 2-mm slices in a mouse brain matrix. Slices were placed in 2% TTC so lution, followed by 10% formalin overnight (Morikawa et a!., 1994a). The infarction area, outlined in white, was measured (Bioquant IV image analysis system) on the posterior surface of each section, and infarction volume was calculated by summing the infarct volume of sequen tial 2-mm-thick sections.
In randomly selected mice, regional CBF (rCBF) was determined by laser-Doppler flowmetry (PF2B; Perimed, Stockholm, Sweden) and recorded on a MacLab/8 data acquisition system (AD Instruments, Milford, MA, U.S.A.). Two fiberoptic probe tips (Perimed PF 319:2, diameter = 0.5 mm) were fixed 2 mm posterior and 3 mm lateral to bregma and 2 mm posterior and 6 mm lateral to bregma on the ipsilateral hemisphere. These two coordi nates identify sites on the convex brain surface within the vascular territory supplied by distal and proximal seg- Vol, 16, No, 5, 1996 ments of the MCA, respectively, and they correspond to periinfarct zone and deeply ischemic territory, respec tively (Huang et aL, 1994; Yang et aL, 1994) . Steady-state baseline values were recorded before MCA occlusion. rCBF was recorded continuously during and after isch emia and expressed as percentage relative to the baseline value.
In protocol 1, MCA occlusion was produced in SV-129 (n = 12), C57 Black (n = 11), eNOS mutant mice (n = 14), and eNOS mutant mice injected with hydralazine (l mg/kg i.p. 1 h before and 5 and 17 h after MCA occlusion; n = 10) to match the arterial blood pressure of wild-type mice (as determined in preliminary experiments).
In protocol 2, eNOS mutant and wild-type animals were injected with nitro-L-arginine (6 mg/kg, i.p. 5 min and 3 and 6 h after ischemia) or an equivalent volume of saline vehicle to test the hypothesis that inhibition of nNOS activity alleviated ischemic brain injury. The investigator was blinded to the treatment group in this protocoL Autoregulation study.
Mice were anesthetized with urethane (1 .5 g/kg, i.p.) and ventilated (SAR-830 ventilator; CWE, Ardmore, PA, U ,S.A.) with 70/30% nitrous oxide/oxygen after tracheot omy, Both femoral arteries were cannulated for arterial blood pressure measurement, blood gas determination, and blood withdrawaL Respiratory parameters were ad justed to keep the Pac0 2 in normal ranges (3�0 mm Hg). The core temperature was kept normothermic as de scribed. The level of rCBF was monitored by laser Doppler flowmetry (Dalkara et aL, 1995) .
Following reflection of the skin and subcutaneous tis sue, an rCBF probe tip was secured directly over the parietal skull with glue (Borden, Columbus, OH, U.S.A.), away from pial vessels. An initial rCBF record ing was taken as 100% and subsequent flow changes were expressed relative to this value. After heparin 00 units i. v.) administration, arterial blood pressure was lowered -10 mm Hg every 5 min by withdrawing femoral artery blood (0.05-0.15 mI). Corresponding rCBF readings were averaged for each IO-mm Hg stepwise reduction. The du ration of total experiment was �2-2.5 h. The upper limit of autoregulation was not tested in these mice.
Closed cranial window preparation and pial vessel diameter measurement
The mouse head was fixed in a stereotaxic frame and the skull exposed by a longitudinal skin incision. A stain less-steel cranial window ring (8.0 mm in inner diameter, 2.0 mm in height) containing three ports was embedded into a loop of bone wax over the skull. Dental acrylic was then applied. A craniotomy (2 x 1.5 mm) was made in the left parietal bone within the ring of the window. After the dura was opened and the brain surface superfused with artificial CSF (aCSF), a cover glass was placed to close the window. The volume under the window was �0.1 mL The composition of aCSF was as follows (in mmoIlL): Na+ 156.5, K+ 2.95, Ca2+ 1.25, Mg 2 + 0.67, Cl-138.7, HC03 -24.6, dextrose 3.7, and urea 0.67. The pH value of aCSF was kept at 7.35-7.45 and monitored continu ously with a pH meter (Corning, Corning, NY, U.S.A.). The aCSF was superfused by an infusion pump (0.4 mIl min) via PE-100 tubing connected to a window port. In tracranial pressure was maintained at 5-8 mm Hg. The temperature of aCSF within the windows was maintained at 36.5-37.0°e. Pial vessels were visualized through a cranial window by an intravital microscope (Leitz, Germany) equipped with a video camera (C2400; Hamamatsu Photonics, Ha mamatsu, Japan). The diameter of a single pial arteriole (20-30 /-Lm) was continuously measured by a video width analyzer (C3161; Hamamatsu) and recorded using the Mac Lab data acquisition and analysis system. After base line stabilization, nitro-L-arginine or nitro-o-arginine so lution (1 mM) was superfused into the window and the diameter of pial arteriole measured continuously 40 min thereafter.
Statistical analysis
Data are expressed as means ± SD. Statistical evalua tion was performed by analysis of variance (ANOV A) followed by t test to compare the data among groups in protocol 1. Unpaired Student t test was used to test the significance between two groups in protocol 2 and rCBF measurement. ANOV A with repeated measures and ANOV A followed by t test were used to evaluate signif icance within group differences and individual points be tween groups in the autoregulation experiment. Probabil-
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RESULTS
As reported previously (Huang et aI. , 1995) , the mean arterial blood pressures in eNOS mutant mice were higher (l 15 ± 8 mm Hg) than in wild-type animals (98 ± 7 and 94 ± 7 mm Hg in SV-129 and C57 Black/6, respectively). After hydralazine ad ministration, however, MABP did not differ be tween groups (Table 1) .
In protocol I, wild-type SV -129 and C57 Black/6 developed infarcts that were 37 ± 7% (n = 12) and 38 ± 15% (n = 11) of their respective hemispheres. Larger infarct volumes (46 ± 9% of hemisphere, n = 14, p < 0.05 as compared with wild-type SV-129 and C57 Black/6) were measured in eNOS mutant mice. Larger infarct volumes were also recorded in 25 * ... eNOS mutant mice made normotensive by hydral azine treatment (48 ± 7% of hemisphere, n = 10, p < 0.05 vs. wild-type SV-129 or C57 B/6) ( Fig. 1 ). There were no significant group differences in phys iology or blood gases before and 24 h after MCA occlusion to explain these differences (Table 1) . rCBF reduction was greater in the zone corre sponding to the peri infarct area in eNOS mutant mice (30 ± 16% of baseline, n = II, p < 0.05) than in SV-129 (40 ± 13% of baseline, n = 10) (Fig. 2) , although there was no significant difference in the MCA core territory (data not shown).
When arterial blood pressure was lowered step wise by controlled hemorrhagic hypotension, CBF stayed relatively constant until <40 mm Hg. How ever, at low blood pressures, the autoregulation curve was shifted slightly to the right in eNOS mu tant animals, suggesting higher cerebrovascular re sistance than in wild type at lower perfusion pres sures (Fig. 3) .
In protocol 2, administration of nitro-L-arginine decreased infarct volume in the eNOS mutant mice by 24% and injury volumes became equivalent to those in wild type. Nitro-L-arginine treatment, how ever, did not change lesion size after MCA occlu sion in wild-type mice ( Table 2) . Unlike in wild-type mice, nitro-L-arginine super fusion alone increased vessel diameter in eNOS mu tant animals, reaching maximum at 30 min (p < 0.05 vs. wild-type) (Fig. 4) . Similar changes in rCBF were recorded in preliminary experiments by laser Doppler tlowmetry using the closed cranial window technique (data not shown). There was no change in MABP during nitro-L-arginine superfusion. No change was found in pial diameter after nitro-D arginine superfusion in eNOS mutant mice (data not shown).
DISCUSSION
Deletion of the mouse eNOS gene is associated with larger brain infarcts after MCA occlusion. Based upon inspection (dissecting microscope) of the circle of Willis after intracardiac Evans blue in jection in SV-129, C57/Black, and eNOS mutant Urethane-anesthetized eNOS mutant mice (dashed line) showed greater decreases in rCBF during hemorrhagic hypotension than wild-type SV-129 animals (solid line). Hy potension was induced by gradually withdrawing arterial blood (see Materials and Methods), and rCBF was measured by laser-Doppler flowmetry. The initial rCBF values were taken as 100% and the corresponding changes thereafter calculated as percentage relative to the initial value. The baseline MABPs in wild-type and mutant were 104 ± 12 (n = 7) and 117 ± 13 (n = 7) mm Hg, respectively. There was a greater tendency toward hypoperfusion at higher levels of MABP in the mutant animals. Data are expressed as means ± SO. *p < 0.05 as compared with wild-type animals. See text for abbreviations. mice (n = 5lgroup), this result could not be ac counted for by vascular anatomical differences. eNOS mutants exhibit more pronounced rCBF re ductions in corresponding brain regions after MCA occlusion and exhibit proportionally lower rCBFs at reduced perfusion pressures during controlled hemorrhagic hypotension (Figs. 2 and 3) . The latter may be due to hypertension, although no hyperten sive changes were noted in the vessel wall on pre liminary histopathological analyses (P. Huang et aI., unpublished data). The contribution of high blood pressure to infarct enlargement was probably minor in this instance because infarct size did not change in eNOS mutants made normotensive by hy dralazine administration. Second, nitro-L-arginine decreased infarct vol ume in eNOS mutant mice, and we presume this decrease was caused by nNOS inhibition, the only constitutively expressed isoform in the eNOS mu tant. However, it is possible that nitro-L-arginine induced vasodilation and possible rCBF increases provided a second mechanism, and additional blood flow studies are needed to clarify this point. Infarct sparing after nitro-L-arginine was not as robust as expected (24% decrease), possibly because nNOS inhibition was subtotal. In the eNOS mutant, nitro L-arginine superfusion inhibits nNOS within subja cent brain parenchyma (W. Meng et aI., unpub lished data), and there is published evidence of a contribution from parenchymally derived NO to ce rebrovascular tone that could negatively impact on ischemic outcome during enzyme inhibition (lade cola et aI., 1994). NO or a closely related chemical is proposed as endothelium-derived relaxing factor (lgnarro et aI., 1987; Palmer et aI., 1988) . There is evidence to sup port the hypothesis that endothelium-derived NO or reaction products may be beneficial to stroke by augmenting rCBF in the ischemic territory. We pre viously reported that infusion of L-arginine, a sub strate for NOS, caused NO-dependent vasodilation and increased rCBF distal to MCA occlusion in rats (Morikawa et aI., 19940) . Dynamic susceptibility contrast magnetic resonance imaging also suggests that L-arginine infusion increases CBF and blood volume (Hamberg et aI., 1993) . Zhang et ai. (1994) reported that NO donors improved rCBF in the ischemic area and reduced infarct size as well. In addition, sectioning of NOS-containing parasympa thetic cerebrovascular fibers in sphenopalatine gan glia (Nozaki et aI., 1993) increased infarct size after focal ischemia (Kano et aI., 199 1) and reduced ce rebral perfusion during hemorrhagic hypotension (Koketsu et aI., 1992) . This evidence coupled with our observation that arterial blood pressures are less stable in eNOS mutant animals (e.g., during hypercapnic challenge) (unpublished data) speak to the importance of eNOS in regulation of vascular hemodynamics and its potential importance to stroke outcome. eNOS mutant mice may be more susceptible to ischemic injury because NO modulates the micro circulation. Rosenblum and colleagues (1992) showed that NO protects the endothelium of mouse pial arterioles from platelet aggregation after vessel wall injury. NO may also block leukocyte adhesion and decrease microvascular stasis often seen fol lowing MCA occlusion (Garcia et aI., 1993) . Kubes and colleagues (199 1) reported that superfusing mesenteric vessels with NOS inhibitors increased leukocyte adhesion. Kurose et al. (1994) found that L-arginine attenuated ischemia-induced platelet leukocyte aggregation, mast cell degranulation, and albumin extravasation. We also found that rCBF was more severely reduced in homologous brain ar eas after MCA occlusion in eNOS but not nNOS (Huang et aI., 1994) mutant mice. These findings confirm that NO plays a role in the modulation of the microcirculation that may contribute to the out come of ischemia.
We have speculated that eNOS inhibition ac counts for the increases in infarct size in some stud ies after nitro-L-arginine, particularly after large doses (Yamamoto et aI., 1992; Zhang and ladecola, 1993; Morikawa et aI., 1994b) . By contrast, neuro protection was reported after selective nNOS inhi bition with 7 -nitroindazole (Yoshida et aI., 1994) or FPLl7477 (Zhang et aI., 1995) . Consistent with the present findings, infarction size increased (Huang et aI., 1994) when nitro-L-arginine was administered to mutant mice expressing only the eNOS isoform (i.e., nNOS knockout mice). Importantly, iNOS en zyme activity is not measurable in mouse (SY -I 29 strain) brain for at least 4 days after permanent MCA occlusion (Yoshida et aI., 1995) .
We do not believe that the protective effect of the eNOS gene is due to eNOS in neurons. In fact, neuronal eNOS expression appears to be more fo cal, site specific (hippocampus) (Dinerman et aI., 1994) , and at lower levels of activity than nNOS expression. For example, we presume that the small amount of residual NOS in nNOS mutants is due to eNOS activity. In nNOS mutants, brain NADPH diaphorase staining disappears almost completely, enzymatic NOS activity is reduced by 95% in brain (Huang et aI., 1993) , and specific eH]nitro-L-arginine binding approaches back ground levels (H. Hara et aI., 1996) . For these rea sons, we believe that infarct sparing after nitro-L arginine is most likely secondary to nNOS inhibi tion in eNOS mutants.
We conclude that NO possesses a dual role in focal cerebral ischemia. Depending upon its source, NO may be toxic or protective to brain under isch emic conditions. Parenchymal NO overproduction may lead to neurotoxicity, whereas endothelial NO may protect brain tissue by increasing rCBF or some other hemodynamic mechanism. Our findings emphasize the need to develop selective inhibitors of the neuronal isoform to protect brain from injury. Our results also emphasize the importance of knockout mice to dissect the role of individual pro teins in complex pathophysiological events.
